Clinical-stage biopharmaceutical company has appointed Cris Calsada as its new chief financial officer (CFO) following her 20 years’ experience in the life sciences and technology industries.
Calsada joins the Spanish group from Ambrx, where she was most recently chief operating officer and vice president of finance.
Prior to this, she served as executive director of finance at Sony Online Entertainment.
Joan Perelló, chief executive officer of Sanifit, said: “We are excited to welcome Cris to our senior leadership team, her strong leadership and first-hand expertise in the financial and strategic operations of clinical stage therapeutics development will be instrumental as we grow our business and advance our pipeline.”